ZipRecruiter

Log In

1

Contract Biotech Investor Relations Jobs (NOW HIRING)

Jade Biosciences

About Jade Biosciences Jade Biosciences is a clinical-stage biotechnology company focused on ... Role Overview Jade Biosciences is seeking a Director, Investor Relations to help build and execute ...

Travere

Analyst, Investor Relations

San Diego, CA · On-site

Department: 101200 Investor Relations Location: San Diego Be a part of a global team that is ... Strong interest in capital markets, investing, biotechnology, healthcare, and current events ...

Zenas BioPharma

Director, Investor Relations

Waltham, MA · Hybrid

$188K - $235K/yr

Zenas BioPharma is seeking an accomplished Director of Investor Relations to lead the development ... biotechnology or the life sciences; experience in a publicly traded biotech company strongly ...

Azenta

Vice President, Investor Relations

Burlington, MA · On-site

$248K - $310K/yr

The Vice President, Investor Relations will lead Azenta's global investor relations strategy and ... Experience in life sciences, healthcare, biotech, or technology enabled services strongly preferred ...

Azenta

Vice President, Investor Relations

Burlington, MA · On-site

$248K - $310K/yr

The Vice President, Investor Relations will lead Azenta's global investor relations strategy and ... Experience in life sciences, healthcare, biotech, or technology enabled services strongly preferred ...

Atlantic Group - New York

Be Seen First

Investor Relations Associate

Dallas, TX · On-site

$35 - $50/hr

This position is a full-time contract role with the opportunity to become permanent based on ... investor relations. Schedule: Hybrid - 4 days in the office, 1 day remote. Responsibilities ...

Atlantic Group - New York

Be Seen First

Investor Relations Associate

Dallas, TX · On-site

$35 - $50/hr

This position is a full-time contract role with the opportunity to become permanent based on ... investor relations. Schedule: Hybrid - 4 days in the office, 1 day remote. Responsibilities ...

next page

Showing results 1-20

All JobsContract Biotech Investor Relations Jobs

Contract Biotech Investor Relations information

See salary details

$31K

$101.1K

$191K

How much do contract biotech investor relations jobs pay per year?

As of Aug 7, 2026, the average yearly pay for contract biotech investor relations in the United States is $101,099.00, according to ZipRecruiter salary data. Most workers in this role earn between $62,000.00 and $134,500.00 per year, depending on experience, location, and employer.

What are the key skills and qualifications needed to thrive as a contract biotech investor relations professional?

To thrive as a Contract Biotech Investor Relations professional, you need a solid background in finance, biotechnology, and communications, often supported by a relevant degree and industry experience. Familiarity with financial modeling tools, investor databases, CRM systems, and compliance platforms is typically required. Exceptional interpersonal skills, strategic thinking, and the ability to distill complex scientific concepts for diverse stakeholders are crucial soft skills in this role. These competencies are essential for building investor trust, ensuring regulatory compliance, and effectively communicating a company's value proposition to the financial community.

What is the difference between Contract Biotech Investor Relations vs Contract Biotech Communications?

AspectContract Biotech Investor RelationsContract Biotech Communications
Primary FocusManaging investor relations, financial communication, and shareholder engagementDeveloping public relations, media outreach, and brand messaging
Required SkillsFinancial analysis, investor communication, regulatory complianceMedia relations, content creation, branding strategies
Work EnvironmentCorporate offices, investor meetings, financial eventsMedia outlets, marketing agencies, corporate communications teams

Contract Biotech Investor Relations primarily focuses on managing relationships with investors and communicating financial information, while Contract Biotech Communications emphasizes public relations and brand messaging. Both roles require strong communication skills but serve different strategic purposes within biotech companies.

What are the main challenges faced by a contract biotech investor relations professional when communicating complex scientific information to investors?

A Contract Biotech Investor Relations professional often faces the challenge of translating intricate scientific data and clinical trial results into clear, compelling messages that investors can understand. Balancing technical accuracy with investor accessibility is crucial, as miscommunication can impact investor confidence and company reputation. Additionally, keeping up with rapidly evolving scientific developments and regulatory updates, while responding promptly to investor inquiries, requires strong communication and project management skills.

What is a contract biotech investor relations professional?

Contract Biotech Investor Relations professionals are specialists hired on a temporary or project basis to manage communications between biotechnology companies and their investors. They help ensure that all investor communications, financial disclosures, and company updates are clear, compliant, and strategically aligned with the company's goals. These professionals often support fundraising efforts, prepare investor materials, coordinate meetings, and handle inquiries from current or potential investors. Their expertise helps biotech companies build and maintain strong relationships with the investment community, especially during pivotal events such as clinical trial announcements or capital raises.
What cities are hiring for Contract Biotech Investor Relations jobs? Cities with the most Contract Biotech Investor Relations job openings:
What are the most commonly searched types of Biotech Investor Relations jobs? The most popular types of Biotech Investor Relations jobs are:
What states have the most Contract Biotech Investor Relations jobs? States with the most job openings for Contract Biotech Investor Relations jobs include:
Contract Biotech Investor Relations jobs near you
Infographic showing various Contract Biotech Investor Relations job openings in the United States as of July 2026, with employment types broken down into 1% Locum Tenens, 2% As Needed, 89% Full Time, 1% Part Time, 1% Temporary, and 6% Contract. Highlights an 82% Physical, 3% Hybrid, and 15% Remote job distribution, with an average salary of $101,099 per year, or $48.6 per hour.

Director, Investor Relations

Jade Biosciences

On-site, Remote

Full-time

Posted 4 days ago

Job description

About Jade Biosciences
Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. Jade's lead candidate, JADE101, targets the cytokine APRIL, and is currently being evaluated in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. Jade's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, as well as JADE301, an undisclosed antibody candidate, both currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount. For more information, visit JadeBiosciences.com and follow the Company on LinkedIn.
Role Overview
Jade Biosciences is seeking a Director, Investor Relations to help build and execute a high caliber investor relations function for a publicly traded biotechnology company. The Director will play a central role in communicating Jade's strategy, pipeline, scientific rationale, clinical development progress, financial position, and value proposition to a primarily investor audience, including institutional investors, sell-side analysts, bankers, and other capital markets stakeholders.
This role requires a strong understanding of biotechnology equity markets, clinical-stage company strategy, and investor-facing communications. The ideal candidate will be able to translate complex scientific, clinical, regulatory, and financial information into clear, credible, and compelling messaging for sophisticated external audiences. Former sell-side biotechnology research professionals are encouraged to apply, including candidates who served as research associates supporting biotechnology or healthcare coverage.
This is a remote role reporting to the Chief Financial Officer and will require periodic travel for investor conferences, investor roadshows, medical and scientific meetings, company meetings, and Board or leadership events.
Key Responsibilities
  • Support the development and execution of Jade's investor relations strategy in partnership with the CFO, CEO, and senior leadership team.
  • Develop and refine investor messaging, Q&A, presentation materials, SEC filings, earnings or corporate update materials, investor conference materials, and other external communications.
  • Serve as a key point of contact for investors and sell-side analysts, helping ensure timely, accurate, consistent, and Regulation FD-compliant communications.
  • Translate complex scientific, clinical, regulatory, competitive, and financial information into clear investor-facing narratives tailored to public market audiences.
  • Monitor investor sentiment, analyst commentary, trading dynamics, peer company disclosures, competitive developments, sector trends, and relevant clinical or regulatory catalysts.
  • Prepare briefing materials for executive leadership ahead of investor meetings, conferences, roadshows, analyst calls, and other external engagements.
  • Help maintain and enhance the company's investor materials, including the corporate presentation, investor website content, fact sheets, event calendars, and FAQ documents.
  • Partner cross-functionally with Finance, Legal, Clinical Development, Regulatory, Medical, Corporate Communications, and external advisors to ensure alignment of investor communications.
  • Assist with quarterly reporting processes, including call preparation, scripts, press releases, Q&A preparation, and post-call investor feedback synthesis.
  • Support capital markets activities, investor targeting, ownership analysis, conference strategy, and engagement planning in partnership with external IR, banking, and legal advisors, as appropriate.
  • Develop concise summaries of investor feedback, market perception, and emerging questions for the leadership team and Board of Directors.
  • Maintain strong command of Jade's programs, target indications, competitive landscape, upcoming milestones, and key investor diligence topics.

Qualifications
  • Bachelor's degree required; advanced degree in a scientific, medical, business, finance, or related field preferred.
  • At least 10 years of related experience with 5 to 8+ years of relevant experience in biotechnology investor relations, sell-side equity research, investment banking, corporate strategy, business development, corporate communications, or a related capital markets role.
  • Prior experience as a sell-side biotechnology or healthcare research associate, or comparable experience developing public equity research, investor materials, or clinical-stage company analysis, is highly valued.
  • Strong understanding of public biotechnology company dynamics, including clinical development milestones, regulatory pathways, financing strategy, investor expectations, peer benchmarking, and disclosure considerations.
  • Ability to communicate sophisticated scientific and clinical concepts clearly to institutional investors and analysts, while maintaining scientific accuracy and appropriate caveats.
  • Excellent written and verbal communication skills, with demonstrated ability to create polished investor-facing materials, briefing documents, Q&A, and executive talking points.
  • High attention to detail, strong judgment, discretion with confidential information, and comfort operating in a fast-paced public company environment.
  • Strong analytical skills, including ability to interpret clinical data, financial information, ownership data, analyst reports, and market feedback.
  • Collaborative, proactive, and low-ego working style with the ability to partner effectively across scientific, clinical, finance, legal, and executive functions.
  • Familiarity with Regulation FD and public company disclosure practices preferred.
  • Proficiency with Microsoft PowerPoint, Excel, Word, investor databases, and market intelligence tools; familiarity with FactSet, CapIQ, Bloomberg, Visible Alpha, Ipreo, AlphaSense, or similar platforms is a plus.
  • Willingness to travel periodically for investor conferences, roadshows, company meetings, and other business needs.

Position Location
This is a remote role; periodic travel to team and company events is required.
The anticipated salary range for candidates for this role is $250,000 - $275,000 The final salary offered will depend on several factors, which may include, but not limited to, relevant years of experience, educational background, and geography.
As part of the I-9 verification of authorization to work in the United States, Jade Bioscience participates in E-Verify. To learn more about E-Verify please review this poster.
Jade Biosciences is proud to be an Equal Opportunity employer. All qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected Veteran status, age, or any other characteristic protected by law.

Apply